For investors seeking momentum, WisdomTree U.S. MidCap Dividend Fund (DON - Free Report) is probably on the radar now. The fund just hit a 52-week high and is up nearly 16% from its 52-week low price of $31.65/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
DON in Focus
The fund tracks the performance of dividend-paying mid-cap companies in the U.S. equity market. Consumer Discretionary (21.98%), Real Estate (16.17%), and Industrials (14.92%) are the top three sectors. The product charges 38 bps in fees (see Mid Cap ETFs here).
Why the Move?
Mid-caps are an often-overlooked investing option. These securities are viewed as big and safe compared to the highly volatile small-cap exposure. But when compared to the stability of large caps, these are relatively risky bets.
Mid-cap stocks are more domestically-focused than large caps and are thus less exposed to geopolitical risks and negative currency translations. Also, after the solid rally on trade war tensions, most small-cap ETFs are trading at a rich valuation now. Such overvaluation concerns have probably led investors toward this mid-cap ETF to tap the solid U.S. economic growth potential.
More Gains Ahead?
It seems that the fund will perform decently in the near term given a positive weighted alpha of 12.10.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, WisdomTree U.S. MidCap Dividend Fund (DON - Free Report) is probably on the radar now. The fund just hit a 52-week high and is up nearly 16% from its 52-week low price of $31.65/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
DON in Focus
The fund tracks the performance of dividend-paying mid-cap companies in the U.S. equity market. Consumer Discretionary (21.98%), Real Estate (16.17%), and Industrials (14.92%) are the top three sectors. The product charges 38 bps in fees (see Mid Cap ETFs here).
Why the Move?
Mid-caps are an often-overlooked investing option. These securities are viewed as big and safe compared to the highly volatile small-cap exposure. But when compared to the stability of large caps, these are relatively risky bets.
Mid-cap stocks are more domestically-focused than large caps and are thus less exposed to geopolitical risks and negative currency translations. Also, after the solid rally on trade war tensions, most small-cap ETFs are trading at a rich valuation now. Such overvaluation concerns have probably led investors toward this mid-cap ETF to tap the solid U.S. economic growth potential.
More Gains Ahead?
It seems that the fund will perform decently in the near term given a positive weighted alpha of 12.10.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DON - FREE